Back to Search Start Over

461 - Visible disease at baseline accelerates time to exit from MRI-based active surveillance.

Authors :
Stavrinides, V.
Giganti, F.
Orczyk, C.
Punwani, S.
Allen, C.
Kirkham, A.
Freeman, A.
Whitaker, H.
Emberton, M.
Moore, C.M.
Source :
European Urology Supplements. Mar2019, Vol. 18 Issue 1, pe607-e607. 1p.
Publication Year :
2019

Subjects

Subjects :
*DISEASES
*WATCHFUL waiting

Details

Language :
English
ISSN :
15699056
Volume :
18
Issue :
1
Database :
Academic Search Index
Journal :
European Urology Supplements
Publication Type :
Academic Journal
Accession number :
135601630
Full Text :
https://doi.org/10.1016/S1569-9056(19)30448-8